0001225208-17-019019.txt : 20171222 0001225208-17-019019.hdr.sgml : 20171222 20171222145738 ACCESSION NUMBER: 0001225208-17-019019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171220 FILED AS OF DATE: 20171222 DATE AS OF CHANGE: 20171222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeFord John A CENTRAL INDEX KEY: 0001403373 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 171272478 MAIL ADDRESS: STREET 1: C R BARD INC STREET 2: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 doc4.xml X0306 4 2017-12-20 0000009892 BARD C R INC /NJ/ BCR 0001403373 DeFord John A C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 Sr. VP Sci Tech and Clin Afrs Common Stock 2017-12-20 4 M 0 4161.0000 136.3700 A 20950.2316 D Common Stock 2017-12-20 4 M 0 3767.0000 168.8650 A 24717.2316 D Common Stock 2017-12-20 4 M 0 3293.0000 186.4250 A 28010.2316 D Common Stock 2017-12-20 4 M 0 2886.0000 219.5550 A 30896.2316 D Common Stock 2017-12-20 4 S 0 900.0000 334.1189 D 29996.2316 D Common Stock 2017-12-20 4 S 0 13207.0000 333.4341 D 16789.2316 D Common Stock 83.8200 I 401(k) Plan Option (Right to Buy) 186.4250 2017-12-20 4 M 0 3293.0000 0.0000 D 2025-12-09 Common Stock 3293.0000 6586.0000 D Option (Right to Buy) 168.8650 2017-12-20 4 M 0 3767.0000 0.0000 D 2024-12-10 Common Stock 3767.0000 3768.0000 D Option (Right to Buy) 136.3700 2017-12-20 4 M 0 4161.0000 0.0000 D 2023-12-11 Common Stock 4161.0000 0.0000 D Option (Right to Buy) 219.5550 2017-12-20 4 M 0 2886.0000 0.0000 D 2026-12-14 Common Stock 2886.0000 8658.0000 D Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. Includes 0.0887 shares acquired under the Company's Dividend Reinvestment Plan from February 4, 2017 to August 4, 2017. Includes 0.0020 shares acquired under the Company's Employee Stock Purchase Plan from February 7, 2017 to August 7, 2017. Represents the weighted average sales price for price increments ranging from $333.97 to $334.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Represents the weighted average sales price for price increments ranging from $332.96 to $333.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Includes 3.904 shares acquired under the Company's 401(k) Plan from May 4, 2017 to August 4, 2017. Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Of this option grant 3,293 options vested on December 9, 2017 and the remaining options vest in two annual installments beginning on December 9, 2018. Of this option grant 3,767 options vested on December 10, 2017 and the remaining options vest on December 10, 2018. Options vested on December 11, 2017. Of this option grant 2,886 options vested on December 14, 2017 and the remaining options vest in three annual installments beginning on December 14, 2018. Myra McGinley, Attorney-in-Fact 2017-12-22